Expression Pathology Inc.

Expression Pathology is a leader in clinical applications of tissue proteomics. We are developing new tests that will guide and improve cancer treatment decisions. The tests will provide information about the protein pathways that drive tumor growth and help select the therapy best suited for particular patient.

Our Liquid Tissue®-SRM technology platform makes possible highly multiplexed quantitation by powerful Selected Reaction Monitoring (SRM) mass spectrometry of minute amounts of laser microdissected formalin-fixed paraffin-embedded (FFPE) tissue using our proprietary Liquid Tissue® sample processing and DIRECTOR® Fast Forward Microdissection.

Expression Pathology offers its DIRECTOR® Laser Microdissection Slides and Liquid Tissue® MS Protein Prep Kits to customers interested in undertaking their own research studies employing these enabling technologies.